Acute respiratory and urinary tract infections Infections and Infestations
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. General practitioners (GP) 2. Registered as physician with the "Association of Statutory Health Insurance Physicians" located in Baden-Wuerttemberg, Bavaria, Bremen, Hesse, Lower Saxony, North Rhine, Saarland, Schleswig-Holstein, Westphalia-Lippe 3. Prescription sum score >2 (sum score ranges from 0 to 6; a GP or GP practice obtains one or two points if its own value in one of the following aspects exceeds the 75% percentile of antibiotic prescribing within the respective region: 3.1. Overall prescription rate (ratio of patients with antibiotic prescriptions to patients with any prescription), one point 3.2. Prescription rate for upper respiratory tract infections (ratio of patients with upper respiratory tract infection to antibiotic prescriptions for these patients), one point 3.3. Prescription rate for lower respiratory tract infections (ratio of patients with lower respiratory tract infection to antibiotic prescriptions for these patients), one point 3.4. Prescription rate of fluoroquinolones; two points: Total prescription rate of fluoroquinolones (ratio of patients with fluoroquinolone to patients with antibiotic) and/or fluoroquinolone prescription rate for urinary tract infection (ratio of urinary tract infection patients with fluoroquinolone to urinary tract infection patients with antibiotics 3.5. Prescription rate of cephalosporins (ratio of patients with cephalosporin to patients with antibiotic); one point
Exclusion criteria
Exclusion criteria: Participation on the predecessor project RESIST
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physicians' overall rate of antibiotic prescriptions, measured as the proportion of patients with antibiotic prescriptions out of all patients with a prescription before intervention and after it starts | — |
Secondary
| Measure | Time frame |
|---|---|
| Physicians' overall prescription rates before and after the intervention for cephalosporins and fluoroquinolones separately | — |
Countries
Germany